Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Intramuscular Tozinameran Booster in Dermatologic Patients
NCT05406908Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by Mahidol University. Started Jun 2022; status: completed.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05406908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05406908.